ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2535

Strategies to Embrace Living with Lupus Fearlessly (SELF): A Promising Digital Intervention for Lupus Self-Management

Katherine Carpenter1, Melissa French2, Sarah Gilman3, Sara Johnson4, Patricia Castle4, S. Sam Lim5, Charmayne Dunlop-Thomas5, Melicent Miller1 and Mary Crimmings1, 1Lupus Foundation of America, Washington, DC, 2Lupus Foundation of America, Alexandria, VA, 3Wayfinder Health Strategies, Falls Church, VA, 4Pro-Change Behavior Systems, Inc., Narragansett, RI, 5Emory University, Atlanta, GA

Meeting: ACR Convergence 2023

Keywords: education, patient, health behaviors, Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Patient Outcomes, Preferences, & Attitudes II: Patient Experience

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: The Lupus Foundation of America (LFA) has engaged in a 5-year cooperative agreement with the Centers for Disease Control and Prevention to implement a digital lupus self-management (SM) intervention based on the Transtheoretical Model of Change. Strategies to Embrace Living with Lupus Fearlessly (SELF) is designed to help users adopt 4 key lupus SM behaviors shown to have the highest impact on health and functional status: managing symptoms, managing stress, managing medications, and working with your healthcare team (each behavior includes 3-5 skills).

Methods: SELF offers user-tailored SM activities, symptom/medication trackers, a journal, links to LFA educators/peer support, and tailored text message tips. Onboarding and 90-day follow-up assessments collect demographics, stage of change for the 4 key SM behaviors , and patient-reported outcomes (PROs) such as measures of physical and mental health. Users select one SM behavior as a focus for a 2-week period. Activities are tailored to stage of change for that focus behavior. Users ‘master a skill’ if they improve from a skill-building stage at onboarding to a mastery stage at follow-up (Figure 1).

SELF was launched in January 2022 and promoted to people with lupus (PWL) via LFA and a patient registry. Utilization and outcomes were evaluated in January, 2023 for users who registered during the prior year.

Results: A total of 3,427 PWL registered for SELF, and 51% completed the onboarding assessment (n=1742) to gain access to the program.

Among SELF users for whom follow-up data were available (n=173), 46% (n=79) mastered 1 or more SM skills with many users mastering more (Figure 2); 52% experienced less fatigue ( p < .001, d = 0.33); 37% reported better overall physical health (p = .007, d = 0.22); 41% reported better mental health (p = .001, d = 0.28); 59% improved medication adherence (p = .004, d = 0.36); and 59% improved doctor-patient communication (p = .035, d = 0.16). For those who did not complete a follow-up assessment (n-1569), the impact of SELF cannot be known, but users completed 8.1 SM activities on average (range = 0 – 224). Enrollment disengagers (n=1685) did not complete the onboarding assessment. The engagement groups were similar (demographics in Table 1), but those who completed follow-up assessments had a higher average age, longer duration since diagnosis, and a higher percentage of Black, non-Hispanic users.

Conclusion: Improvements to SM skill development and PROs show that SELF is a promising program for building skills and impacting outcomes for PWL. Low engagement at onboarding and follow-up assessments indicates a need to ease response burden. While results need more study, it is notable that more users who completed the follow-up assessment were Black, a group historically experiencing greater health disparities.

Acknowledgement: The authors are grateful for the support of Kamil Barbour, Public Health Advisor for the Centers for Disease Control and Prevention.

Supporting image 1

Figure 1. Transtheoretical Model of Change (TTM) is shown with stages of change and progression of improvement to mastery.

Supporting image 2

Table 1. User demographics are shown for three distinct groups: Enrollment disengagers (people who registered for SELF but did not complete the onboarding assessment), SELF users who did not complete a 90-day follow-up assessment and SELF users who completed a 90-day follow-up assessment.

Supporting image 3

Figure 2. Among SELF users who completed the follow-up assessment, 46% mastered one or more additional SM skills. Across the 4 key SM behaviors, SELF users improved the % of skills mastered from onboarding assessment to follow-up assessment in every category.


Disclosures: K. Carpenter: None; M. French: None; S. Gilman: None; S. Johnson: None; P. Castle: None; S. Lim: None; C. Dunlop-Thomas: None; M. Miller: None; M. Crimmings: None.

To cite this abstract in AMA style:

Carpenter K, French M, Gilman S, Johnson S, Castle P, Lim S, Dunlop-Thomas C, Miller M, Crimmings M. Strategies to Embrace Living with Lupus Fearlessly (SELF): A Promising Digital Intervention for Lupus Self-Management [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/strategies-to-embrace-living-with-lupus-fearlessly-self-a-promising-digital-intervention-for-lupus-self-management/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/strategies-to-embrace-living-with-lupus-fearlessly-self-a-promising-digital-intervention-for-lupus-self-management/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology